A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder - Medori, R; Ramos-Quiroga, J A; Casas, M (Biol Psychiatry, 2008)
et al.